Prescribing, Policies and Pathways
The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| A frequently asked questions document - NHS Shared care and specialist guided prescribing service specification | Shared Care | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Acetylcholinesterase (AChE) inhibitor | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Acetylcholinesterase (AChE) inhibitor | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Alternatives To Admission | East and North Hertfordshire | n/a | Clinical pathways | East and North Hertfordshire | |
| Alternatives To Admission | West Essex | n/a | Clinical policy | West Essex | |
| Alternatives To Admission| South West Hertfordshire | n/a | Clinical pathways | South and West Hertfordshire | |
| Amiodarone | Arrythmia | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Amiodarone Review Pathway | Arrythmia | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Atomoxetine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Atomoxetine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | West Essex |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol | Amber protocol | Shared care protocol | West Essex |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol children and young people (methylphenidate, lisdexamfetamine, dexamfetamine, atomoxetine or guanfacine) | Amber protocol | Shared care protocol | West Essex |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol - children, young people and adults | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Azathioprine / mercaptopurine | Multisystem autoimmune disease | Amber protocol | Shared care protocol | West Essex |
| Azathioprine / mercaptopurine | Multisystem autoimmune disease | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Cinacalcet | Secondary Hyperparathyroidism in Adults with End Stage Kidney Disease Requiring Renal Replacement Therapy | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Clinical brand prescribing guidance | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Dapsone | Licensed Indications | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Denosumab | Osteoporosis | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Denosumab letter template | Osteoporosis | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Denosumab prescribing support document | Osteoporosis | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Dexamfetamine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Dexamfetamine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | West Essex |
| Donepezil | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Donepezil | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Dronedarone - Adults | Arrythmia | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Fludrocortisone | Orthostatic Hypotension | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Galantamine | Alzheimer's disease dementia | Amber initiation | Decision document | East and North Hertfordshire, South and West Hertfordshire |
| Galantamine | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Guanfacine | Atttention deficit hyperactivity disorder (ADHD) - in children | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Guanfacine | Atttention deficit hyperactivity disorder (ADHD) - in children | Amber protocol | Shared care protocol | West Essex |
| Hydroxycarbamide | Myeloproliferative neoplasms | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Ivabradine | stable angina and chronic heart failure | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Lanthanum | Hyperphosphataemia in adult patients with chronic kidney disease | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Leflunomide | Rheumatoid Arthritis, Psoriatic Arthritis | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Liothyronine | Hypothyroidism | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Liothyronine - Position Statement | Hypothyroidism | Amber protocol | Position statement | Hertfordshire and West Essex ICB |
| Liothyronine – Information for Patients | Hypothyroidism | Amber protocol | Patient information | Hertfordshire and West Essex ICB |
| Liothyronine Review Algorithm | Hypothyroidism | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Lisdexamfetamine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Lisdexamfetamine | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | West Essex |
| Lithium | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | Amber protocol | Shared care protocol | West Essex |
| Lithium | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Memantine | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Memantine | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Methotrexate | Autoimmune disease | Amber protocol | Shared care protocol | West Essex |
| Methotrexate | Autoimmune disease | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Methylphenidate | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Methylphenidate | Attention deficit hyperactivity disorder (ADHD) | Amber protocol | Shared care protocol | West Essex |
| Midodrine | Orthostatic Hypotension | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Modern Slavery and Human Trafficking | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Mycophenolate mofetil | Multisystem autoimmune disease | Amber protocol | Shared care protocol | West Essex |
| Mycophenolate mofetil | Multisystem autoimmune disease | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Penicillamine | Rheumatoid Arthiritis | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Penicillamine | Tertiary care indication (NHSE) | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Riluzole | Amyotrophic Lateral Sclerosis (ALS) form of Motor Neurone Disease (MND) | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Rivastigmine | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Rivastigmine | Alzheimer's disease dementia | Amber protocol | Shared care protocol | West Essex |
| Safeguarding | n/a | Patient information | Hertfordshire and West Essex ICB | |
| Sevelamer | Hyperphosphateemia in adult patients with chronic kidney disease | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Shared Care | Shared Care Principles | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Shared care | Attention deficit hyperactivity disorder (ADHD) by Private Provider | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Shared care | Initiation by a Private Provider | Amber protocol | Patient information | Hertfordshire and West Essex ICB |
| Sirolimus oral | Transplant rejection (prescribe by brand) NHSE for existing patients | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Sodium valproate | All indications | Amber initiation | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Somatropin | Treatment of adults with growth hormone deficiency | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Somatropin | Treatment of growth failure in children | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Sucroferric Oxyhydroxide | Hyperphosphataemia in adult patients with end stage renal failure requiring renal replacement therapy | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Sulfasalazine | Gastroenterology / Rheumatology | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Tacrolimus oral | Transplant rejection (prescribe by brand) NHSE for existing patients | Amber protocol | n/a | Hertfordshire and West Essex ICB |